213 related articles for article (PubMed ID: 28933757)
1. The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.
Cao P; McCaw JM
Viruses; 2017 Jul; 9(8):. PubMed ID: 28933757
[TBL] [Abstract][Full Text] [Related]
2. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
[TBL] [Abstract][Full Text] [Related]
3. Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.
Li K; Cao P; McCaw JM
Viruses; 2021 May; 13(5):. PubMed ID: 34066999
[TBL] [Abstract][Full Text] [Related]
4. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
[TBL] [Abstract][Full Text] [Related]
5. Understanding the within-host dynamics of influenza A virus: from theory to clinical implications.
Hadjichrysanthou C; Cauët E; Lawrence E; Vegvari C; de Wolf F; Anderson RM
J R Soc Interface; 2016 Jun; 13(119):. PubMed ID: 27278364
[TBL] [Abstract][Full Text] [Related]
6. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.
Holthausen DJ; Lee SH; Kumar VT; Bouvier NM; Krammer F; Ellebedy AH; Wrammert J; Lowen AC; George S; Pillai MR; Jacob J
Immunity; 2017 Apr; 46(4):587-595. PubMed ID: 28423338
[TBL] [Abstract][Full Text] [Related]
7. Modeling within-host dynamics of influenza virus infection including immune responses.
Pawelek KA; Huynh GT; Quinlivan M; Cullinane A; Rong L; Perelson AS
PLoS Comput Biol; 2012; 8(6):e1002588. PubMed ID: 22761567
[TBL] [Abstract][Full Text] [Related]
8. The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?
Wu W; Metcalf JP
J Innate Immun; 2020; 12(6):437-447. PubMed ID: 32564033
[TBL] [Abstract][Full Text] [Related]
9. Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
Shim JM; Kim J; Tenson T; Min JY; Kainov DE
Viruses; 2017 Aug; 9(8):. PubMed ID: 28805681
[TBL] [Abstract][Full Text] [Related]
10. Influenza A: New Therapeutic Targets for a Deadly Disease.
Manzano D; Izquierdo-Garcia JL; Martín-Loeches I; Lorente JA
Arch Bronconeumol (Engl Ed); 2019 Jun; 55(6):295-296. PubMed ID: 30409486
[No Abstract] [Full Text] [Related]
11. Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.
Elbahesh H; Gerlach T; Saletti G; Rimmelzwaan GF
Front Immunol; 2019; 10():809. PubMed ID: 31031778
[TBL] [Abstract][Full Text] [Related]
12. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
van de Wakker SI; Fischer MJE; Oosting RS
Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
[TBL] [Abstract][Full Text] [Related]
13. Programmed Cell Death in the Pathogenesis of Influenza.
Fujikura D; Miyazaki T
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30012970
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase inhibitor resistance in influenza viruses.
Reece PA
J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
16. Influenza A Virus: Host-Virus Relationships.
Lal SK
Viruses; 2020 Aug; 12(8):. PubMed ID: 32784813
[TBL] [Abstract][Full Text] [Related]
17. Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response.
Ma LL; Wang HQ; Wu P; Hu J; Yin JQ; Wu S; Ge M; Sun WF; Zhao JY; Aisa HA; Li YH; Jiang JD
Free Radic Biol Med; 2016 Jul; 96():347-61. PubMed ID: 27107768
[TBL] [Abstract][Full Text] [Related]
18. Simulation and prediction of the adaptive immune response to influenza A virus infection.
Lee HY; Topham DJ; Park SY; Hollenbaugh J; Treanor J; Mosmann TR; Jin X; Ward BM; Miao H; Holden-Wiltse J; Perelson AS; Zand M; Wu H
J Virol; 2009 Jul; 83(14):7151-65. PubMed ID: 19439465
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
20. Host species barriers to influenza virus infections.
Kuiken T; Holmes EC; McCauley J; Rimmelzwaan GF; Williams CS; Grenfell BT
Science; 2006 Apr; 312(5772):394-7. PubMed ID: 16627737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
